SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934

April 10, 2017
Commission File Number: 001-34559

Syneron Medical Ltd.
(Translation of registrant’s name into English)

Industrial Zone, Yokneam Illit 20692, P.O.B. 550, Israel
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
 
Form 20-F ☒   Form 40-F  £

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant  to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
 
Yes ☐   No  S
 
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ________

Attached hereto as Exhibit 99.1 and incorporated herein by reference is the Registrant's Notice of Special General Meeting of Shareholders to be held on June 15, 2017.

Also attached as Exhibit 99.2 is a proxy card in connection the Registrant's Special General Meeting of Shareholders to be held on June 15, 2017 .  The proxy card is attached for informational purposes only, and the Company will not accept executed proxy cards until after May 8, 2017, the record date of the Special General Meeting of Shareholders, and after the Company submits on Form 6-K a proxy statement related to the Special General Meeting of Shareholders.

This Form 6-K is incorporated by reference into the Company’s Registration Statements on Form S-8 filed with the Securities and Exchange Commission on November 16, 2004 (Registration No. 333-120559), on January 8, 2010 (Registration No. 333-164250), on January 15, 2010 (Registration No. 333-164351), on December 9, 2013 (Registration No. 333-192729) and on September 8, 2016 (Registration No. 333-213539).


 
Signatures
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
SYNERON MEDICAL LTD.
 
 
 
 
 
 
By:
/s/ Hugo Goldman
 
 
 
Name: Hugo Goldman
 
Date: April 10, 2017
 
Title: Chief Financial Officer
 
 
 
2

 
 
 
 
Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Syneron Medical Ltd. - Ordinary Shares Charts.
Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Syneron Medical Ltd. - Ordinary Shares Charts.